Literature DB >> 12582327

Spectrum of ocular allergy.

Stefan D Trocme1, Karan K Sra.   

Abstract

PURPOSE OF REVIEW: To elaborate and review the immunologic spectrum of the five basic types of ocular allergy. RECENT
FINDINGS: Perennial allergic conjunctivitis (PAC) appears to be an extension of seasonal allergic conjunctivitis (SAC) based on the similarity of clinical symptoms and the immune mechanism involved. T helper type 2 (TH2)-type cytokines, increased ratio of TH1/TH2 cytokines and increased statement of adhesion molecules all appear to play an integral role in the inflammatory process of SAC and PAC. Vernal keratoconjunctivitis (VKC), which is a pediatric disease, differs from SAC and PAC by its more severe and chronic nature. Increased numbers of T cells, eosinophils (along with the products of degranulation), chemokines and their receptors may contribute to the more serious symptoms of VKC. Atopic keratoconjunctivitis (AKC) is similar to VKC by the increased concentration of cytokines involved (i.e. interleukin-4 and -5). Despite clinical similarities with VKC, the presence of atopic dermatitis, along with some differences in clinical signs, make AKC a separate entity, which is sometimes referred to as an adult variant of VKC. Giant papillary conjunctivitis has similar cell involvement as VKC and AKC. However, giant papillary conjunctivitis differs from VKC and AKC by the clinical signs present (i.e. the presence of giant papillae) and the necessary concurrent contact lens wear.
SUMMARY: The important differences and similarities observed in these five types of allergic diseases might help to better treat the patients affected with these disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12582327     DOI: 10.1097/00130832-200210000-00010

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  8 in total

1.  B and T lymphocyte attenuator regulates the development of antigen-induced experimental conjunctivitis.

Authors:  Waka Ishida; Ken Fukuda; Mina Kajisako; Tamaki Sumi; Hironori Matsuda; Hideo Yagita; Atsuki Fukushima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-22       Impact factor: 3.117

2.  Toll-like receptor 4 signalling attenuates experimental allergic conjunctivitis.

Authors:  S-H Chung; S H Choi; K J Cho; C-K Joo
Journal:  Clin Exp Immunol       Date:  2011-03-10       Impact factor: 4.330

3.  Conjunctival macrophages act as antigen-presenting cells in the conjunctiva during the development of experimental allergic conjunctivitis.

Authors:  Waka Ishida; Ken Fukuda; Mina Kajisako; Ayako Takahashi; Tamaki Sumi; Nico van Rooijen; Atsuki Fukushima
Journal:  Mol Vis       Date:  2010-07-10       Impact factor: 2.367

4.  Conjunctival Inclusion Cysts in Long-standing Chronic Vernal Keratoconjunctivitis.

Authors:  Seung-Won Lee; Seung-Chan Lee; Kyung-Hyun Jin
Journal:  Korean J Ophthalmol       Date:  2007-12

5.  Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis.

Authors:  Ajit Kumar Hazarika; Prodip Kumar Singh
Journal:  J Nat Sci Biol Med       Date:  2015-08

6.  Curcumin suppresses ovalbumin-induced allergic conjunctivitis.

Authors:  So-Hyang Chung; Seong Hyun Choi; Jin A Choi; Roy S Chuck; Choun-Ki Joo
Journal:  Mol Vis       Date:  2012-07-18       Impact factor: 2.367

7.  Context-Dependent Regulation of Conjunctival Goblet Cell Function by Allergic Mediators.

Authors:  Laura García-Posadas; Robin R Hodges; Yolanda Diebold; Darlene A Dartt
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

8.  Trifuhalol A Suppresses Allergic Inflammation through Dual Inhibition of TAK1 and MK2 Mediated by IgE and IL-33.

Authors:  Sim-Kyu Bong; No-June Park; Sang Heon Lee; Jin Woo Lee; Aaron Taehwan Kim; Xiaoyong Liu; Sang Moo Kim; Min Hye Yang; Yong Kee Kim; Su-Nam Kim
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.